| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.003 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |